Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
11 pending office actions • 8 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Sorbonne Université currently manages 3 pending office actions within the Chemistry & Materials technology area. These actions are distributed across 3 distinct examiners and 3 distinct art units. This distribution indicates that each pending case is being reviewed by a different examiner in a different department, which suggests a variety of technical focuses within the company's chemistry portfolio. The presence of 3 distinct art units requires a strategy that addresses the specific procedural nuances of each department involved in the Chemistry & Materials sector.
The busiest examiner is WANG, EUGENIA, who is responsible for 1 busiest_examiner_pending action. Since the total number of pending actions is 3 and the busiest examiner handles 1, the workload is spread across the 3 distinct examiners. Practitioners should prepare for 3 different examination styles, as no single examiner or art unit dominates the current pending applications. Managing 3 pending office actions across 3 distinct examiners requires a decentralized approach to prosecution, ensuring that each application is tailored to the specific expectations of the individual examiner assigned to the case.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (36%) |
| §103 only | 1 (9%) |
| §112 only | 1 (9%) |
| Double-patenting only | 1 (9%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 3 (27%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AMICK, THOMAS RUSSE | 1 | 73.1% | +30.4% |
| WRIGHT, ERIC BRANDON | 1 | — | — |
| POHNERT, STEVEN C | 1 | 12.4% | +18.5% |
| GOLDBERG, JEANINE ANNE | 1 | 45.8% | +40.8% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 42.9% | +57.1% |
| DARRIGRAND, EMILY ANN | 1 | — | — |
| RAMIREZ, DELIA M | 1 | 65.1% | +56.3% |
| JEBUTU, MOFOLUWASO SIMILOLUWA | 1 | 34.8% | +40.3% |
| BURKHART, MICHAEL D | 1 | 62.3% | +11.7% |
| GOMES, SRISTI DIVINA | 1 | 25.0% | -33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | BUCHANAN, BAILEY CHEYENNE | 100d overdue |
| 18273389 | A Method for Diagnosing Endometrial or Ovarian Carcinoma | GOLDBERG, JEANINE ANNE | 23d overdue |
| 18554161 | METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING | POHNERT, STEVEN C | — |
| 18006030 | TRAINING METHOD AND MODEL FOR PREDICTING INHIBITORS OF DRUGS METABOLIZING ENZYMES | DARRIGRAND, EMILY ANN | — |
| 17926160 | USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION | RAMIREZ, DELIA M | — |
| 17790075 | PH SENSOR DEVICE INTENDED TO BE INSERTED INTO THE GROUND, METHOD FOR MEASURING PH, IN PARTICULAR FOR CATHODIC PROTECTION | JEBUTU, MOFOLUWASO SIMILOLUWA | — |
| 17766311 | SYSTEM FOR THE AUTOMATIC EVALUATION OF COGNITION AND CONSCIOUSNESS OF AN INDIVIDUAL THROUGH EXTERNAL STIMULATIONS | GOMES, SRISTI DIVINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | BUCHANAN, BAILEY CHEYENNE | 100d overdue |
| 18273389 | A Method for Diagnosing Endometrial or Ovarian Carcinoma | GOLDBERG, JEANINE ANNE | 23d overdue |
| 18772744 | CONSTRUCTS COMPRISING NEURONAL VIABILITY FACTORS AND USES THEREOF | AMICK, THOMAS RUSSE | — |
| 18554161 | METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING | POHNERT, STEVEN C | — |
| 17926160 | USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION | RAMIREZ, DELIA M | — |
| 17790075 | PH SENSOR DEVICE INTENDED TO BE INSERTED INTO THE GROUND, METHOD FOR MEASURING PH, IN PARTICULAR FOR CATHODIC PROTECTION | JEBUTU, MOFOLUWASO SIMILOLUWA | — |
| 17768002 | GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND ITS USE THEREOF IN THE TREATMENT OF CANCER | BURKHART, MICHAEL D | — |
| Art Unit | Apps |
|---|---|
| 1682 | 2 |
| 1632 | 1 |
| 1683 | 1 |
| 1652 | 1 |
| 1795 | 1 |
| 1638 | 1 |
| 3791 | 1 |
| 1728 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18772744 | CONSTRUCTS COMPRISING NEURONAL VIABILITY FACTORS AND USES THEREOF | AMICK, THOMAS RUSSE | — | DP | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18491138 | G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD) | WRIGHT, ERIC BRANDON | 1632 | §102§103§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18554161 | METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING | POHNERT, STEVEN C | 1683 | §101§103§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18273389 | A Method for Diagnosing Endometrial or Ovarian Carcinoma | GOLDBERG, JEANINE ANNE | 1682 | §101§102§112 | Final Rejection | 23d overdue | Pending | Jul 20, 2023 |
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | BUCHANAN, BAILEY CHEYENNE | 1682 | §101§102§103§112 | Final Rejection | 100d overdue | Pending | Jan 26, 2023 |
| 18006030 | TRAINING METHOD AND MODEL FOR PREDICTING INHIBITORS OF DRUGS METABOLIZING ENZYMES | DARRIGRAND, EMILY ANN | — | §101§102§103§112 | Non-Final OA | — | Pending | Jan 19, 2023 |
| 17926160 | USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION | RAMIREZ, DELIA M | 1652 | §103§112Other | Final Rejection | — | Pending | Nov 18, 2022 |
| 17790075 | PH SENSOR DEVICE INTENDED TO BE INSERTED INTO THE GROUND, METHOD FOR MEASURING PH, IN PARTICULAR FOR CATHODIC PROTECTION | JEBUTU, MOFOLUWASO SIMILOLUWA | 1795 | §103§112 | Final Rejection | — | Pending | Jun 29, 2022 |
| 17768002 | GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND ITS USE THEREOF IN THE TREATMENT OF CANCER | BURKHART, MICHAEL D | 1638 | §112 | Final Rejection | — | Pending | Apr 11, 2022 |
| 17766311 | SYSTEM FOR THE AUTOMATIC EVALUATION OF COGNITION AND CONSCIOUSNESS OF AN INDIVIDUAL THROUGH EXTERNAL STIMULATIONS | GOMES, SRISTI DIVINA | 3791 | §103§112 | Final Rejection | — | Pending | Apr 04, 2022 |
| 17622065 | LAYERED ACTIVE MATERIAL FOR NA-ION BATTERIES | ALBAN, FELICITY BERNARD | 1728 | §103 | Final Rejection | — | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial